NasdaqCM - Nasdaq Real Time Price USD

Cryoport, Inc. (CYRX)

Compare
8.56
+0.40
+(4.90%)
As of 3:05:19 PM EST. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jerrell W. Shelton Chairman, President & CEO 865.6k 5.94M 1945
Mr. Robert S. Stefanovich MS CFO & Treasurer 547.64k 553.53k 1965
Mr. Edward J. Zecchini Senior VP and Chief Digital & Technology Officer 85k -- 1962
Dr. Mark W. Sawicki Ph.D. Chief Scientific Officer 547.64k 130 --
Mr. Thomas J. Heinzen Vice President of Corporate Development & Investor Relations -- -- --
Mr. Tony Ippolito VP, General Counsel & Corporate Secretary -- -- --
Ms. Kylie A. Crowe Vice President of Global Human Resources & Organizational Development -- -- --
Mr. Phil Wilson Chief Operating Officer of Cryoport Systems, LLC -- -- --

Cryoport, Inc.

112 Westwood Place
Suite 350
Brentwood, TN 37027
United States
949 470 2300 https://www.cryoportinc.com
Sector: 
Industrials
Full Time Employees: 
1,100

Description

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Corporate Governance

Cryoport, Inc.’s ISS Governance QualityScore as of January 1, 2025 is 5. The pillar scores are Audit: 5; Board: 7; Shareholder Rights: 6; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 10, 2025 at 10:59 AM UTC - March 14, 2025 at 12:00 PM UTC

Cryoport, Inc. Earnings Date

Recent Events

November 7, 2024 at 10:00 PM UTC

Q3 2024 Earnings Call

November 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 8, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 14, 2024 at 12:00 AM UTC

S-8: Offering Registrations

May 30, 2024 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 8, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 3, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

Related Tickers